Since climate change and global warming are wreaking havoc, exposure to climate risk insights is vital because it helps in the right course of action. As a result, Informatica Intelligent Data ...
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in ...
The IDMC conducted an in-depth evaluation of interim safety data from 89 enrolled patients and found no significant safety concerns that would impact the trial's continuation. To date, Daewoong has ...
(RTTNews) - SELLAS Life Sciences Group, Inc. (SLS), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, Thursday ...
GUANGZHOU, China, July 2, 2025 /PRNewswire/ -- Bio-Thera Solutions, Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, today ...
A record 75.9 million people are living in internal displacement due to conflict, and nearly half that number is in sub-Saharan Africa, according to a recent report. The report from the Internal ...
Informatica’s latest release brings self-service tuning, LLM integration, and model governance to the forefront of enterprise data management. Informatica is adding new AI-based capabilities to its ...
Third Independent Data Monitoring Committee (IDMC) review confirms safety and continuation of the study 94 patients enrolled out of 102 planned across Korea and the U.S. Interim baseline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback